Price To Earnings Ratio 11.33 | Sector PE 59.59 |
PB Ratio 1.39 | Sector PB 8.75 |
EPS 10.46 | Dividend Yield 2.87 |
Today's Volume 824.033 K | 5 Day Avg. Volume 635.964 K |
PEG Ratio 0.28 | Market Cap. ₹ 3,430.00 Cr. |
Time | ALEMBICLTD | VS | Industry |
---|---|---|---|
1 Day | -3.07% | -3.22% | |
1 Week | -13.09% | -5.8% | |
1 Month | -16.04% | -4.68% | |
6 Months | -10% | 16.04% | |
1 Year | -10% | 50.81% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 131.59 | Bearish |
20 | 134.58 | Bearish |
30 | 138.28 | Bearish |
50 | 143.84 | Bearish |
100 | 135 | Bearish |
200 | 114.8 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | ||||
---|---|---|---|---|---|---|---|
Operating Activities | 22.69 | 38.85 | -17.75 | ||||
Investing Activities | 25.84 | 7.30 | 18.85 | ||||
Financing Activities | -48.19 | -46.39 | -5.82 | ||||
Net Cash Flow | 0.33 | -0.24 | -4.72 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Alembic | -3.07 | -13.09 | -16.04 | -10 | -10 |
Aurobindo Pharma | -0.97 | -2.16 | -2.84 | 24.09 | 54.91 |
Fortis Healthcare | -2.55 | -5.38 | -3.01 | 23.62 | 74.56 |
Ajanta Pharmaceuticals | -6.64 | -11.6 | -5.55 | 30.65 | 61.04 |
Advanced Enzyme Tech | -3.64 | -9.26 | -20.37 | 8.43 | 32.9 |
Alembic Limited is an Indian company that develops, manufactures and markets pharmaceutical products such as dosage forms and active ingredients. The company operates through one segment, Pharmaceuticals. The Pharmaceutical segment manufactures and markets fermentation and chemical-based active ingredients (API). The company also conducts R&D in Vadodara. The company manufactures/provides three main products/services: Azithromycin, Venlafaxine and Telmisartan.